BIRK

Analyst Note: BIRK (Birkenstock Holding plc)

Date: 2026-06-13 Current Price: $46.11

1. Structural Readiness

State: Forming Aggressive/Pre-Breakout Entry: N/A (Current price is within the consolidation range) Breakout Level: Not yet defined (Pending confirmation of the resistance cap) Current Price: $46.11 Extension: N/A (Price is within the coil, not extended above entry) ATR Context: Current ATR is 5.0% (High). This indicates elevated volatility, which is consistent with the "Quality Compounder" archetype during a consolidation phase where the market is digesting recent growth data.

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None named at this date. Analysis: This is a tactical, setup-led name. There is no named secular macro thesis driving the immediate setup. The conviction must be derived strictly from the quality of the structural setup (the forming coil) and the underlying business fundamentals as reported by management. We do not invent a thesis; we judge the name on the strength of its execution and the structural integrity of the price action.

3. Business Overview

Company Profile: Birkenstock Holding plc is a London-headquartered subsidiary of BK LC Lux MidCo S.à r.l., established in 1774. The company specializes in the creation and distribution of foot-related products, including sandals, shoes, closed-toe designs, skincare items, and accessories. Business Model: The company operates a hybrid model combining Direct-to-Consumer (DTC) channels (owned retail stores and e-commerce) with wholesale partnerships. As of the fiscal year ended September 30, 2025, the DTC channel represented 38% of revenues. Industry & Competition: The company operates in the footwear, skincare, accessories, and sleep system industries. Management explicitly notes that these industries are "very competitive" and that the company expects to face "intense competition." Key Operational Metrics (as of Q2 2026 Earnings, May 13, 2026):

• Revenue Growth: Q2 revenues grew over 14% in constant currency, landing within the target range of 13% to 15%.
• Product Mix: Closed-toe penetration increased by 300 basis points, driven by strong growth in clogs.
• Retail Expansion: Own retail grew over 60% in constant currency. The company opened 5 new owned retail doors in the quarter, bringing the global total to 111. Management is on track to meet the target of 140 doors by the end of fiscal 2026.
• Guidance: Management reiterated targets for fiscal 2026: constant currency revenue growth of 13% to 15% and adjusted EBITDA of at least EUR 700 million (implying a margin of 30% to 30.5%, inclusive of 200 bps pressure from FX and tariffs).
• Geopolitical Context: Management acknowledges significant uncertainty due to tariffs imposed by the U.S. administration in April 2025 and subsequent countermeasures by the EU.
• Risk Factors: The business is highly concentrated on a single discretionary product category (footwear), making it vulnerable to shifts in consumer preferences. Additionally, the company may need to increase marketing spend to penetrate growth markets (Asia, Middle East) and underserved segments in core markets.

4. Archetype and Conviction

Archetype: Quality Compounder Fit Rationale: The name fits the "Quality Compounder" archetype due to its consistent execution against guidance, strong DTC expansion, and ability to maintain margin targets despite macro headwinds (tariffs/FX). The "Quality" aspect is evidenced by the 30%+ EBITDA margin and the 14% revenue growth. The "Compounder" aspect is reflected in the strategic expansion of the owned retail network (111 doors, targeting 140) and the diversification into closed-toe products (clogs) to mitigate category risk. Valuation Context: The financial spine indicates a forward consensus EPS of $2.00 for FY1 and $2.43 for FY2. Conviction Stack:

• Thesis Strength: Low (Tactical only, no macro thesis).
• Evidence Quality: High. Management has provided specific, reiterated guidance (13-15% growth, 30%+ margins) and concrete operational milestones (111 doors, 60% DTC growth).
• Structural Quality: Moderate to High. The forming coil suggests a healthy consolidation after a run-up, with price holding above support.
• Setup Readiness: Partial. The coil is forming, not confirmed.
• Rerating Potential: Dependent on the successful breakout of the forming coil and continued execution of the 140-door target.

5. Invalidations, Strengtheners, and Gaps

Gaps in Evidence:

• Specific Breakout Level: The exact price level for the breakout (resistance cap) is not defined in the provided evidence, only the existence of the forming structure.
• Forward Guidance beyond FY26: No specific guidance is provided for fiscal 2027 or beyond, limiting the long-term view to the "longer-term targets" mentioned generally in January 2026.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: Q2 revenue growth of 14% within target range; reiterated FY26 guidance of 13-15% growth and 30%+ EBITDA margin; strong DTC growth of 60% and 111 owned doors with clear path to 140. Key risks: High concentration in discretionary footwear category; intense competition in footwear and skincare; geopolitical uncertainty from tariffs and FX volatility; elevated current ATR of 5.0% indicating volatility risk. Expected path: Management expects to meet the 140-door target by end of FY26; if the forming coil resolves to the upside, the stock should re-rate based on the sustained 13-15% growth trajectory. Expected horizon: 3 to 6 months for the structural setup to resolve (breakout or invalidation).